<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Pain</journal-id><journal-title>Molecular Pain</journal-title><issn pub-type="epub">1744-8069</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1744-8069-5-33</article-id><article-id pub-id-type="pmid">19563686</article-id><article-id pub-id-type="doi">10.1186/1744-8069-5-33</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>PKC&#x003b5;-dependent potentiation of TTX-resistant Na<sub>v</sub>1.8 current by neurokinin-1 receptor activation in rat dorsal root ganglion neurons</article-title></title-group><contrib-group><contrib id="A1" equal-contrib="yes" contrib-type="author"><name><surname>Cang</surname><given-names>Chun-Lei</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>cangcl@gmail.com</email></contrib><contrib id="A2" equal-contrib="yes" contrib-type="author"><name><surname>Zhang</surname><given-names>Hua</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Hua.Zhang@ucsf.edu</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Zhang</surname><given-names>Yu-Qiu</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>yuqiuzhang@fudan.edu.cn</email></contrib><contrib id="A4" corresp="yes" contrib-type="author"><name><surname>Zhao</surname><given-names>Zhi-Qi</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>zqzhao@fudan.edu.cn</email></contrib></contrib-group><aff id="I1"><label>1</label>Institute of Neurobiology, Institutes of Brain Science and State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai 200032, PR China</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>30</day><month>6</month><year>2009</year></pub-date><volume>5</volume><fpage>33</fpage><lpage>33</lpage><ext-link ext-link-type="uri" xlink:href="http://www.molecularpain.com/content/5/1/33"/><history><date date-type="received"><day>6</day><month>3</month><year>2009</year></date><date date-type="accepted"><day>30</day><month>6</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Cang et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Cang et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Cang Chun-Lei cangcl@gmail.com </dc:author><dc:title> PKC&#x003b5;-dependent potentiation of TTX-resistant Nav1.8 current by neurokinin-1 receptor activation in rat dorsal root ganglion neurons </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>Molecular Pain 5(1): 33-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1744-8069(2009)5:1&#x0003c;33&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1744-8069</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Substance P (SP), which mainly exists in a subtype of small-diameter dorsal root ganglion (DRG) neurons, is an important signal molecule in pain processing in the spinal cord. Our previous results have proved the expression of SP receptor neurokinin-1 (NK-1) on DRG neurons and its interaction with transient receptor potential vanilloid 1 (TRPV1) receptor.</p></sec><sec><title>Results</title><p>In this study we investigated the effect of NK-1 receptor agonist on Na<sub>v</sub>1.8, a tetrodotoxin (TTX)-resistant sodium channel, in rat small-diameter DRG neurons employing whole-cell patch clamp recordings. NK-1 agonist [Sar<sup>9</sup>, Met(O<sub>2</sub>)<sup>11</sup>]-substance P (Sar-SP) significantly enhanced the Na<sub>v</sub>1.8 currents in a subgroup of small-diameter DRG neurons under both the normal and inflammatory situation, and the enhancement was blocked by NK-1 antagonist Win51708 and protein kinase C (PKC) inhibitor bisindolylmaleimide (BIM), but not the protein kinase A (PKA) inhibitor H89. In particular, the inhibitor of PKC&#x003b5;, a PKC isoform, completely blocked this effect. Under current clamp model, Sar-SP reduced the amount of current required to evoke action potentials and increased the firing rate in a subgroup of DRG neurons.</p></sec><sec><title>Conclusion</title><p>These data suggest that activation of NK-1 receptor potentiates Na<sub>v</sub>1.8 sodium current via PKC&#x003b5;-dependent signaling pathway, probably participating in the generation of inflammatory hyperalgesia.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Substance P (SP), a member of tachykinin family, is a well-known pain-related neuropeptide in the spinal cord. It is released by unmyelinated primary afferent fiber terminals of small-diameter dorsal root ganglion (DRG) neurons and participates in the spinal transmission of nociceptive signals [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. It is well documented that the SP receptor neurokinin-1 (NK-1) is densely distributed in the superficial dorsal horn and involved in the development of chronic pain and central sensitization after intense noxious stimulation and tissue/nerve injury [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B7">7</xref>].</p><p>In addition to the expression of the NK-1 on the postsynaptic neurons of superficial spinal dorsal horn, increasing evidence strongly suggested the presynaptic expression of NK-1 in DRG neurons. The immunohistochemical evidence revealed that the NK-1 was expressed by the unmyelinated axons of the glabrous skin [<xref ref-type="bibr" rid="B8">8</xref>], and the DRG neuron soma in rats [<xref ref-type="bibr" rid="B9">9</xref>]. By means of intracellular and whole-cell patch clamp recordings, SP was shown to be able to induce the depolarization of DRG or trigeminal ganglion neurons in the different species [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B13">13</xref>] and potentiated the TRPV1 currents [<xref ref-type="bibr" rid="B9">9</xref>]. However, the function of DRG-expressed NK-1 receptor needs to be further understood.</p><p>The Na<sub>v</sub>1.8, which is a TTX-resistant sodium channel and mainly expressed in small-diameter DRG neurons [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>], is a major contributor to the upstroke of action potential in these neurons [<xref ref-type="bibr" rid="B16">16</xref>]. In the Na<sub>v</sub>1.8-null mice or Na<sub>v</sub>1.8 knockdown mice by antisense oligodeoxynucleotides, both the physiological and pathological pain was alleviated [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B20">20</xref>]. Accumulative evidence showed that the Na<sub>v</sub>1.8 current was regulated by various inflammatory mediators, such as prostaglandin E<sub>2 </sub>(PGE<sub>2</sub>), serotonin, NGF etc. through a PKA or PKC signaling pathway [<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B24">24</xref>]. </p><p>In the present study, we investigated the effects of the NK-1 agonist on dynamics of Na<sub>v</sub>1.8 currents in isolated small-diameter DRG neurons using whole-cell patch clamp recording. Also, the role of PKC signal pathway in the cross-talk between NK-1 and Na<sub>v</sub>1.8 was examined.</p></sec><sec><title>Results</title><sec><title>Recording of Na<sub>v</sub>1.8 currents in DRG neurons</title><p>With existence of TTX (500 nM) in external solution, TTX-resistant sodium currents were recorded in most (166 out of 205) of the small-diameter DRG neurons (&#x0003c;25 &#x003bc;m). The membrane potential was hold to -60 mV. Under this recording condition, TTX-resistant sodium currents were mainly mediated by Na<sub>v</sub>1.8 channels due to inactivation of Na<sub>v</sub>1.9 [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. The family of Na<sub>v</sub>1.8 sodium currents was generated with a voltage-clamp protocol (depolarizing steps from -55 mV to 40 mV, 50 ms, 5 mV increments, Figure <xref ref-type="fig" rid="F1">1A</xref>). In accordance with the current-voltage relationship (Figure <xref ref-type="fig" rid="F1">1B</xref>), -10 mV was chosen to elicit Na<sub>v</sub>1.8 currents in most of the recordings (Figure <xref ref-type="fig" rid="F1">1C</xref>). As reported by Saab et al. [<xref ref-type="bibr" rid="B27">27</xref>], fluoride-based pipette solution also caused slow stabilization of the amplitude of Na<sub>v</sub>1.8 current after rupture of cell membrane in our experiments. We measured the peak amplitude of the Na<sub>v</sub>1.8 current at 5 min, 10 min and 15 min after whole-cell mode was performed. As shown in Figure <xref ref-type="fig" rid="F1">1D</xref>, the peak amplitude was relatively stable from 5 min to 15 min (n = 16). All of our subsequent recordings were performed in this time course.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Recording of Na<sub>v</sub>1.8 currents in rat DRG neurons</bold>. A: representative I-V curve family of currents recorded in the presence of 500 nM TTX is shown, using a protocol (inset) where cells were depolarized to a variety of potentials (-55 to +40 mV) from a holding potential of -60 mV to elicit Na<sub>v</sub>1.8 currents. B: <italic>I-V </italic>curve of Na<sub>v</sub>1.8 currents shown in (A). C: representative traces of Na<sub>v</sub>1.8 current elicited by a single pulse of -10 mV which was used in most of the recordings. D: peak amplitudes of Na<sub>v</sub>1.8 currents elicited by -10 mV pulse at 5 min, 10 min and 15 min after whole-cell mode was performed. The currents were stable during the recording time in all the cells (n = 16).</p></caption><graphic xlink:href="1744-8069-5-33-1"/></fig></sec><sec><title>Increase in peak amplitude of Na<sub>v</sub>1.8 current by Sar-SP</title><p>Following the perfusion with Sar-SP (1 &#x003bc;M, 1 min), a selective NK-1 agonist, Na<sub>v</sub>1.8 currents were increased in 13 out of 30 DRG neurons tested (Figure <xref ref-type="fig" rid="F2">2A, B</xref> and <xref ref-type="fig" rid="F2">2C</xref>). The maximal enhancement of the peak amplitude occurred at 3 min after Sar-SP perfusion, and reduced slowly to control level thereafter (Figure <xref ref-type="fig" rid="F2">2A</xref>). As shown in Figure <xref ref-type="fig" rid="F2">2C</xref>, normalized currents were increased significantly by Sar-SP (116.2 &#x000b1; 2.9%, n = 13) compared with the control (99.2 &#x000b1; 0.5%, n = 16, <italic>p </italic>&#x0003c; 0.001). Higher concentration of Sar-SP (10 &#x003bc;M) failed to induce more powerful action (117.1 &#x000b1; 1.4%, n = 6, <italic>p </italic>&#x0003c; 0.001, Figure <xref ref-type="fig" rid="F2">2C</xref>), suggesting a "ceiling effect" at 1 &#x003bc;M. The Sar-SP-induced potentiation was blocked by co-incubation of Win51708, a selective NK-1 antagonist (5 &#x003bc;M, 98.5 &#x000b1; 0.6%, n = 15, Figure <xref ref-type="fig" rid="F2">2D</xref>). To exclude the influence of fluoride, we also test the effect of Sar-SP by using chloride-based pipette solution. Cesium fluoride was changed to cesium chloride. The effect of Sar-SP wasn't changed significantly (data not shown).</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Effect of NK-1 agonist Sar-SP on Na<sub>v</sub>1.8 currents</bold>. A: time course of the potentiation effect of Sar-SP. The maximal increase in the peak amplitude was at 3 min after Sar-SP perfusion, and reduced slowly to control level thereafter. B: typical traces illustrating the Na<sub>v</sub>1.8 current recorded in a neuron pre- (dashed line, control) and post- (solid line, Sar-SP) perfusion of 1 &#x003bc;M Sar-SP. C: histogram showing the effect of 1 &#x003bc;M and 10 &#x003bc;M Sar-SP. The normalized peak current was enhanced to 116.2 &#x000b1; 2.9% and 117.1 &#x000b1; 1.4% 3 min after perfusion of 1 &#x003bc;M and 10 &#x003bc;M Sar-SP, respectively (***<italic>p </italic>&#x0003c; 0.001, versus control, Kruskal-Wallis one-way ANOVA, n = 16 for control, 13 for 1 &#x003bc;M, and 6 for 10 &#x003bc;M). D: NK-1 antagonist Win51708 (5 &#x003bc;M) completely blocked the effect of Sar-SP in all 15 neurons tested (<italic>p </italic>&#x0003e; 0.05, t-test). E: The rate of the Sar-SP-responsive cells was increased after CFA-treatment. F: The effect of Sar-SP was also increased after peripheral CFA-treatment (* <italic>p </italic>&#x0003c; 0.05, t-test, n = 8 for saline and 14 for CFA-treated). G and H: Sar-SP shifted the activation (G) and steady-state inactivation (H) curve in a hyperpolarizing direction.</p></caption><graphic xlink:href="1744-8069-5-33-2"/></fig><p>The effect of Sar-SP on Na<sub>v</sub>1.8 current was also examined under peripheral inflammation condition. Complete Freund's adjuvant (CFA, 100 &#x003bc;l) was bilaterally injected into rat hind paws. DRG neurons was tested three days after CFA treatment, Na<sub>v</sub>1.8 currents were enhanced by Sar-SP (1 &#x003bc;M) in 60.9% of DRG neurons (n = 23). In the saline treated control rats, 38.1% of DRG neurons (n = 21) exhibited potentiation of Na<sub>v</sub>1.8 current (Figure <xref ref-type="fig" rid="F2">2E</xref>). In rats with CFA treatment, the peak Na<sub>v</sub>1.8 current in DRG neurons was enhanced to 123.2 &#x000b1; 1.8% (n = 14) following application of Sar-SP, whereas enhanced to 117.4 &#x000b1; 1.5% (n = 8) in saline treated control rats (Figure <xref ref-type="fig" rid="F2">2F</xref>, <italic>p </italic>&#x0003c; 0.05). Given inflammation-induced increase in expression of NK-1 [<xref ref-type="bibr" rid="B9">9</xref>], it is suggested that such modulation of NK-1 may be more beneficial for controlling inflammatory chronic pain.</p></sec><sec><title>Sar-SP shifted the activation and steady-state inactivation curves of Na<sub>v</sub>1.8 in a hyperpolarizing direction</title><p>As described above, a voltage-clamp protocol consisted of 50 ms depolarizing steps from -55 mV to 40 mV (5 mV increments) was used to determine the activation of Na<sub>v</sub>1.8 channels. Sar-SP caused a left shift of the activation curve (Figure <xref ref-type="fig" rid="F2">2G</xref>). Half-maximal activation potential (V<sub>1/2activation</sub>) was shifted to -20.03 &#x000b1; 0.23 mV from that of control condition (-14.24 &#x000b1; 0.25, n = 6) after Sar-SP perfusion. The <italic>k </italic>value was not changed by Sar-SP (<italic>k</italic><sub>control </sub>= 4.89 &#x000b1; 0.27, <italic>k</italic><sub>Sar-SP </sub>= 4.77 &#x000b1; 0.45). Steady-state inactivation was determined at a series of membrane potentials from -60 mV to 15 mV (5 mV increments) for 500 ms and a following test potential of 20 mV. Similar to the activation curve, the steady-state inactivation curve was also shifted in a hyperpolarized direction after Sar-SP perfusion (Figure <xref ref-type="fig" rid="F2">2H</xref>). The V<sub>1/2 </sub>of voltage dependence of steady-state inactivation was -19.31 &#x000b1; 0.23 mV (n = 6) using vehicle alone, and -25.55 &#x000b1; 0.14 mV after Sar-SP treatment (n = 6). The <italic>k </italic>value was also not changed by Sar-SP (<italic>k</italic><sub>control </sub>= 5.39 &#x000b1; 0.37, <italic>k</italic><sub>Sar-SP </sub>= 5.09 &#x000b1; 0.32).</p></sec><sec><title>Sar-SP-induced potentiation of Na<sub>v</sub>1.8 via PKC, but not PKA</title><p>Activation of NK-1, a G-protein coupled receptor, triggers several intracellular signal pathways, such as PKA and PKC pathway [<xref ref-type="bibr" rid="B28">28</xref>]. Given modulation of Na<sub>v</sub>1.8 by PKC [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B29">29</xref>], here we used bisindolylmaleimide (BIM), a PKC inhibitor, to examine its effect on the Sar-SP-induced potentiation of Na<sub>v</sub>1.8 currents. In all DRG neurons (n = 24) incubated with BIM (1 &#x003bc;M) for 30 min before Sar-SP perfusion, Sar-SP failed to potentiate Na<sub>v</sub>1.8 currents, suggesting a PKC-dependent mechanism in the interaction of NK-1 and Na<sub>v</sub>1.8 (Figure <xref ref-type="fig" rid="F3">3A</xref> and <xref ref-type="fig" rid="F3">3B</xref>).</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Involvement of PKC, but not PKA in Sar-SP-induced potentiation of Na<sub>v</sub>1.8 currents</bold>. Incubation with PKC inhibitor BIM (1 &#x003bc;M) for 30 min before Sar-SP perfusion completely blocked the potentiation effect of Sar-SP in all 24 neurons tested (A and B, <italic>p </italic>&#x0003e; 0.05, Mann-Whitney rank sum test). After incubation with PKA inhibitor H89, Sar-SP (1 &#x003bc;M) still fully enhanced Na<sub>v</sub>1.8 currents in 9 of 24 DRG neurons (C and D, ***<italic>p </italic>&#x0003c; 0.001, Mann-Whitney rank sum test).</p></caption><graphic xlink:href="1744-8069-5-33-3"/></fig><p>Na<sub>v</sub>1.8 currents were also reported to be regulated by PKA [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. While the cells were incubated with the PKA inhibitor H89 (1 &#x003bc;M) for 30 min, Sar-SP (1 &#x003bc;M) still fully enhanced Na<sub>v</sub>1.8 currents in 9 of 24 DRG neurons (Figure <xref ref-type="fig" rid="F3">3C</xref> and <xref ref-type="fig" rid="F3">3D</xref>, control = 99.2 &#x000b1; 0.5%, Sar-SP = 115.6 &#x000b1; 2.1%, <italic>p </italic>&#x0003c; 0.001), suggesting that the PKA pathway did not participate in the interaction of NK-1 and Na<sub>v</sub>1.8.</p><p>Further, PMA (phorbol 12-myristate 13-acetate), a PKC activator, was used to mimic the effect of Sar-SP. As shown in Figure <xref ref-type="fig" rid="F4">4</xref>, PMA (300 nM) significantly enhanced the Na<sub>v</sub>1.8 currents by 19.5 &#x000b1; 3.2% in 10 out of 13 recorded neurons (<italic>p </italic>&#x0003c; 0.001, Figure <xref ref-type="fig" rid="F4">4A</xref> and <xref ref-type="fig" rid="F4">4B</xref>). Notably, perfusion with Sar-SP (1 &#x003bc;M) failed to further enhance PMA-induced potentiation of Na<sub>v</sub>1.8 currents (118.3 &#x000b1; 2.2%, <italic>p </italic>&#x0003c; 0.001, Figure <xref ref-type="fig" rid="F4">4A</xref> and <xref ref-type="fig" rid="F4">4B</xref>). After PMA perfusion, the activation and steady-state inactivation curves were also shifted in a hyperpolarizing direction (Figure <xref ref-type="fig" rid="F4">4C</xref> and <xref ref-type="fig" rid="F4">4D</xref>). Half-maximal activation potential (V<sub>1/2 activation</sub>) was shifted to -18.97 &#x000b1; 0.28 mV from that of control condition (-14.37 &#x000b1; 0.18 mV, n = 6). The half-maximal inactivation potential (V<sub>1/2 inactivation</sub>) was shifted to -24.48 &#x000b1; 0.10 mV from -19.41 &#x000b1; 0.18 mV (control, n = 6). These results further confirmed that Sar-SP modulated Na<sub>v</sub>1.8 channels in a PKC-dependent pathway. In consistent with Sar-SP, PMA didn't change the <italic>k </italic>value in the activation and inactivation curves (activation: <italic>k</italic><sub>control </sub>= 4.59 &#x000b1; 0.26, <italic>k</italic><sub>PMA </sub>= 4.64 &#x000b1; 0.68; inactivation: <italic>k</italic><sub>control </sub>= 5.39 &#x000b1; 0.37, <italic>k</italic><sub>PMA </sub>= 5.14 &#x000b1; 0.36).</p><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>PMA mimic the effect of Sar-SP</bold>. A and B:representative traces (A) and histogram (B) showing the effect of PMA on Na<sub>v</sub>1.8 currents. 300 nM PMA induced a similar potentiation to 1 &#x003bc;M Sar-SP. Perfusion with Sar-SP failed to further enhance the currents after PMA-induced peak potentiation (***<italic>p </italic>&#x0003c; 0.001, versus control, Kruskal-Wallis one-way ANOVA, n = 16 for control, 10 for PMA and 10 for Sar-SP). PMA also shifted the activation and steady-state inactivation curve of Na<sub>v</sub>1.8 in a hyperpolarized direction (C and D).</p></caption><graphic xlink:href="1744-8069-5-33-4"/></fig></sec><sec><title>PKC&#x003b5;: a pivotal factor for potentiation of Na<sub>v</sub>1.8 by NK-1 activation</title><p>As reported, there are five isoforms of PKC expressed in DRG neurons [<xref ref-type="bibr" rid="B31">31</xref>]. Among these isoforms, PKC&#x003b5; is highly expressed in small-diameter DRG neurons and involved in NK-1 activation-induced potentiation of TRPV1 and the development of hyperalgesia [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B31">31</xref>-<xref ref-type="bibr" rid="B33">33</xref>]. Therefore, to explore the effect of PKC&#x003b5; on Sar-SP-induced potentiation of Na<sub>v</sub>1.8, &#x003b5;V1-2 (200 &#x003bc;M), a specific PKC&#x003b5; inhibitor, was delivered intracellularly via recording electrodes. The potentiation of Na<sub>v</sub>1.8 currents was completely blocked by &#x003b5;V1-2 (n = 15), but not by its negative control (control peptide) (n = 8, Figure <xref ref-type="fig" rid="F5">5A</xref> and <xref ref-type="fig" rid="F5">5B</xref>).</p><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>PKC&#x003b5; was the main PKC subtype mediating the effect of Sar-SP</bold>. A and B: representative traces (A) and histogram (B) showing the effect of PKC&#x003b5; inhibitor &#x003b5;V1-2 on Sar-SP-induced potentiation. Intracellular application of &#x003b5;V1-2 (200 &#x003bc;M) completely abolished the potentiation effect of Sar-SP. The negative control (control peptide) of &#x003b5;V1-2 failed to block Sar-SP-induced potentiation (***<italic>p </italic>&#x0003c; 0.001, versus normal control, one-way ANOVA, n = 16 for normal control, 11 for &#x003b5;V1-2 and 8 for negative control).</p></caption><graphic xlink:href="1744-8069-5-33-5"/></fig></sec><sec><title>Effect of Sar-SP on excitability of DRG neuron</title><p>Na<sub>v</sub>1.8 is the main contributor to the upstroke of action potentials in small-diameter DRG neurons [<xref ref-type="bibr" rid="B16">16</xref>]. Therefore, modulation of this channel by Sar-SP should influence excitability of the DRG neuron. We detected the effect of Sar-SP on the threshold for evoking action potential in DRG neurons. To evoke action potentials, 5 ms step depolarizing current pulses were applied to neurons before and after exposure to Sar-SP (Figure <xref ref-type="fig" rid="F6">6A</xref> and <xref ref-type="fig" rid="F6">6B</xref>). In 6 of 17 neurons tested, Sar-SP significantly decreased the injected current threshold to evoke action potentials. Under the control condition, the current threshold was 116.7 &#x000b1; 7.6 pA. After exposure to Sar-SP, this threshold was reduced to 80.0 &#x000b1; 5.2 pA (Figure <xref ref-type="fig" rid="F6">6C</xref>, n = 6, <italic>p </italic>&#x0003c; 0.01).</p><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>Effect of 1 &#x003bc;M Sar-SP on action potential threshold and firing rate in DRG neurons</bold>. Sar-SP reduced the amount of current required to evoke action potential and increased the firing rate in DRG neurons. Experiments were performed using current clamp model. A and B: depolarizing current pulse required to evoke an action potential in a DRG neuron, before (A) and after (B) application of Sar-SP (a = 130 pA, b = 140 pA, c = 80 pA, d = 90 pA). C: effect of Sar-SP on the threshold for action potential generation by depolarizing current pulse (**<italic>p </italic>&#x0003c; 0.01, paired t-test, n = 6). D and E: firing response of a DRG neuron to a 500 pA depolarizing current pulse (500 ms), before (D) and after (E) application of Sar-SP. F: effect of Sar-SP on firing rate in DRG neurons (***<italic>p </italic>&#x0003c; 0.001, paired t-test, n = 6).</p></caption><graphic xlink:href="1744-8069-5-33-6"/></fig><p>In addition, during injection of supramaximal depolarizing current pulses (500 ms, 500 pA), DRG neurons fired with a frequency at 21.22 &#x000b1; 1.57 Hz (Figure <xref ref-type="fig" rid="F6">6D</xref> and <xref ref-type="fig" rid="F6">6F</xref>, n = 6). Sar-SP significantly increased the firing frequency to 33.22 &#x000b1; 1.53 Hz (Figure <xref ref-type="fig" rid="F6">6E</xref> and <xref ref-type="fig" rid="F6">6F</xref>, n = 6, <italic>p </italic>&#x0003c; 0.001).</p></sec></sec><sec><title>Discussion</title><p>The role of substance P (SP) and its NK-1 receptor in pain processing was widely investigated in the spinal cord. However, most of the prevailing studies focused on the postsynaptic NK-1 receptors in the spinal superficial dorsal horn neurons. Whether NK-1 receptors are also expressed presynaptically in primary sensory neurons is still obscure. A growing body of evidence showed that SP could activate DRG neurons through NK-1 receptor in primary sensory neurons [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>], in despite of a contradictory report [<xref ref-type="bibr" rid="B36">36</xref>]. Our recent study provided new evidence for the expression of NK-1 receptor protein and interaction with TRPV1, a crucial pain signal molecule, in DRG neurons [<xref ref-type="bibr" rid="B9">9</xref>].</p><p>In addition to TRPV1, another important ion channel, TTX-resistant sodium channel, is also primarily expressed in nociceptors. Between the two distinct TTX-resistant sodium channel isoforms Na<sub>v</sub>1.8 and Na<sub>v</sub>1.9, Na<sub>v</sub>1.8 likely mediates the majority of the TTX-resistant currents and plays an important role in pain processing. Na<sub>v</sub>1.8-null mice displayed a pronounced increase in threshold to noxious mechanical stimuli and a slight decrease in nociceptive thermoreception as well as delayed development of inflammatory hyperalgesia [<xref ref-type="bibr" rid="B17">17</xref>]. Likewise, knocking-down of Na<sub>v</sub>1.8 mRNA with antisense oligodeoxynucleotides was effective in alleviating both the inflammatory and neuropathic pain [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. Also, muO-conotoxin MrVIB, a selective blocker of Na<sub>v</sub>1.8, reduced allodynia and hyperalgesia in neuropathic and chronic inflammatory pain models [<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B40">40</xref>]. The present study for the first time revealed that NK-1 activation potentiated Na<sub>v</sub>1.8 currents and shifted both the activation and steady-state inactivation curves of this channel in a hyperpolarizing direction. This change in voltage sensitivity of Na<sub>v</sub>1.8 may decrease the activate threshold and increase the likelihood of action potential firing, and then probably cause a hyperexcitability of the neurons. As shown in Figure <xref ref-type="fig" rid="F6">6</xref>, the enhancement of excitability was observed in our experiments. Although the involvement of Sar-SP-induced modulation on other ion channels still need to be further investigated, it is assumed that modulation on Na<sub>v</sub>1.8 at least partly contributes to this enhancement of excitability. Similar results were also obtained from studies on modulation of Na<sub>v</sub>1.8 by another peripheral pain-related neuropeptide calcitonin gene related peptide (CGRP) [<xref ref-type="bibr" rid="B41">41</xref>] and proinflammatory factors such as 5-hydroxytryptamine and prostaglandin E<sub>2 </sub>[<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>]. It is conceivable that the modulation of Na<sub>v</sub>1.8 by NK-1 activation may contribute to peripheral sensitization of pain pathway.</p><p>NK-1 receptor is a G-protein coupled receptor [<xref ref-type="bibr" rid="B28">28</xref>]. The activation of NK-1 receptors generates various second messengers, which, in turn, trigger a wide range of effector mechanisms underlying regulating cellular excitability and functions [<xref ref-type="bibr" rid="B44">44</xref>-<xref ref-type="bibr" rid="B47">47</xref>]. In agreement with our previous finding that the modulation of TRPV1 by NK-1 receptor was mediated by activation of PLC and downstream PKC pathway [<xref ref-type="bibr" rid="B9">9</xref>], the present results also proved the involvement of PKC in the interaction between NK-1 and Na<sub>v</sub>1.8. As shown in Figure <xref ref-type="fig" rid="F3">3</xref> and Figure <xref ref-type="fig" rid="F4">4</xref>, PKC inhibitor BIM completely blocked Sar-SP-induced potentiation of Na<sub>v</sub>1.8 currents, whereas PKC activator PMA could mimic the effects of Sar-SP on Na<sub>v</sub>1.8 currents. These results suggest that NK-1 modulates Na<sub>v</sub>1.8 in a PKC-dependent pathway. There are many other papers confirmed the enhancement of Na<sub>v</sub>1.8 by PKC pathway [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B49">49</xref>]. However, the inconsistent results have been reported. Gold et al. reported that PKC activation also caused an increase in the amplitude of the TTX-resistant current in rat DRG neurons. But this increase was not associated with a shift in the activation curve [<xref ref-type="bibr" rid="B23">23</xref>]. Vijayaragavan and colleagues reported that in <italic>Xenopus oocytes </italic>expression system, PKC activator PMA caused a decrease of Na<sub>v</sub>1.8 current and a right shift of the activation curve [<xref ref-type="bibr" rid="B29">29</xref>]. The reason for the difference is still unclear.</p><p>Furthermore, we observed that PKC&#x003b5; inhibitor &#x003b5;V1-2 completely blocked Sar-SP-induced potentiation of Na<sub>v</sub>1.8 currents, suggesting that PKC&#x003b5; was the main mediator of NK-1 potentiation, in consistence with the modulation of TRPV1 by NK-1 [<xref ref-type="bibr" rid="B9">9</xref>].</p><p>In addition to the PKC pathway, several reports showed that PKA was also involved in the increase of TTX-resistant currents by proinflammatory agents (5-HT, PGE<sub>2</sub>) [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B42">42</xref>]. However, PKA inhibitor H89 failed to prevent Sar-SP-induced potentiation of Na<sub>v</sub>1.8 in the present study. These suggested the diverse mechanisms underlying modulation of Na<sub>v</sub>1.8 by the different proinflammatory agents. Therefore, the modulatory action of NK-1 may be predominately mediated by PKC, particularly by PKC&#x003b5;, but not PKA.</p><p>It is well documented an increase in expression of Na<sub>v</sub>1.8 in DRG neurons in several inflammatory pain models [<xref ref-type="bibr" rid="B50">50</xref>-<xref ref-type="bibr" rid="B53">53</xref>]. Our previous results have revealed that both the NK-1 expression and phosphorylation of PKC&#x003b5; are up-regulated in DRG after CFA-induced inflammation [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B33">33</xref>]. Therefore, we assume that the modulation of Na<sub>v</sub>1.8 by NK-1 via PKC&#x003b5; is likely to be stronger after peripheral inflammation. In support of this view, the present study showed that not only the effect of NK-1 activation on Na<sub>v</sub>1.8 currents was significantly potentiated, but also the rate of Sar-SP-responsive neurons following CFA treatment. It is conceivable that the modulation of Na<sub>v</sub>1.8 by NK-1 may amplify peripheral nociceptive inputs and in turn strengthen activation of the pain-sensitive neurons in the spinal cord, contributing to inflammatory pain.</p></sec><sec><title>Conclusion</title><p>Substance P (SP) receptor NK-1 and TTX-resistant sodium channel Na<sub>v</sub>1.8 expressed on nociceptors are two important molecules for pain processing. The present study for the first time investigated their interaction in rat DRG neurons. The results showed that activation of NK-1 receptor potentiates Na<sub>v</sub>1.8 sodium current via PKC&#x003b5;-dependent signaling pathway, probably participating in the generation of inflammatory hyperalgesia.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Animals</title><p>Male adult (100&#x02013;150 g) Sprague-Dawley rats (obtained from the Experimental Animal Center, Shanghai Medical College of Fudan University, China) were used in our experiments. Rats were on a 12 h light/dark cycle with a room temperature of 22 &#x000b1; 1&#x000b0;C and received food and water <italic>ad libitum</italic>. All experimental procedures were approved by the Shanghai Animal Care and Use Committee and followed the policies issued by the International Association for the Study of Pain on the use of laboratory animals. All efforts were made to minimize animal suffering and reduce the numbers of animals used.</p></sec><sec><title>Cell preparation</title><p>Culture of DRG neurons was established as described previously [<xref ref-type="bibr" rid="B33">33</xref>]. Briefly, DRGs from L<sub>4</sub>-L<sub>6 </sub>lumbar segments were dissected and incubated at 36.8&#x000b0;C for 25 min in DMEM containing 3 mg/ml collagenase (type IA, Sigma, St. Louis, MO) and, 1 mg/ml trypsin (type I, Sigma). The ganglias were then gently triturated using fine fired-polished Pasteur pipettes. The dissociated DRG neurons were plated onto coverslips (10 mm diameter) in the 3.5 cm culture dishes and incubated with Standard external solution containing (in mM) 150 NaCl, 5 KCl, 2 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 10 HEPES, and 10 glucose, adjusted to pH 7.4 with NaOH.</p></sec><sec><title>Patch-clamp recordings</title><p>Whole-cell voltage-clamp and current-clamp recordings of DRG neurons were performed at room temperature (20&#x02013;22&#x000b0;C) with an EPC-9 amplifier (HEKA Elektronik, Lambrecht/Pfalz, Germany). Stimulation protocols and data acquisition were controlled by the software Pulse and Pulsefit 8.5 (HEKA Elektronik). Neurons were prepared as above, and all recordings were performed within 2&#x02013;8 h after plating. All of the recordings were made from small-diameter (15&#x02013;25 &#x003bc;m) DRG neurons. After gigaohm seal formation and membrane disruption, the whole cell capacitance was cancelled and series resistance was compensated (&#x0003e; 80%). Microelectrodes were fabricated from 1.5 mm out diameter borosilicate capillary glass (Sutter Instruments, Novato, CA) by using a P-97 puller (Sutter Instruments, Novato, CA), and had a resistance of 3&#x02013;5 M&#x003a9;. Electrodes were filled with (in mM): 140 CsF, 1 MgCl<sub>2</sub>, 1 EGTA, 2.5 Na<sub>2</sub>ATP, 10 HEPES, pH was adjusted to 7.2 with CsOH. In recording of Na<sub>v</sub>1.8 currents, the external solution contained (in mM): 32 NaCl, 20 TEA-Cl, 105 choline-Cl, 1 MgCl<sub>2</sub>, 1 CaCl<sub>2</sub>, 0.1 CdCl<sub>2</sub>, 10 HEPES, 0.0005 TTX and 10 glucose, adjusted to pH 7.4 with NaOH. The TEA-Cl, CdCl<sub>2</sub>, TTX was used to inhibit endogenous K<sup>+</sup>, Ca<sup>2+</sup>, and TTX-sensitive sodium currents, respectively. In current-clamp recordings, the electrode solution was changed to: 140 KCl, 1 MgCl<sub>2</sub>, 0.5 CaCl<sub>2</sub>, 5 EGTA, 10 HEPES, 2.5 Na<sub>2</sub>ATP, pH was adjusted to 7.2 with KOH. The external solution was changed to: 150 NaCl, 5 KCl, 2.5 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 10 HEPES, pH was adjusted to 7.4 with NaOH.</p></sec><sec><title>Drugs</title><p>All the drugs were purchased from Sigma (St. Louis, MO, USA), except that the PKC&#x003b5; inhibitor &#x003b5;V1-2 and its negative control were from Biomol (Plymouth Meeting, PA). All the drugs are prepared on the day of the experiment from stocks kept at -20&#x000b0;C at a concentration at least 1000-fold the working concentration. [Sar<sup>9</sup>, Met(O<sub>2</sub>)<sup>11</sup>]-substance P (Sar-SP) and PMA were applied close to the cells through a ALA-VM8 perfusion system (ALA Scientific Instruments, Westbury, NY). Inhibitors were applied (where appropriate) to the chamber for 30 min before the perfusion of Sar-SP and PMA and existed during the whole recording course.</p></sec><sec><title>Data analysis</title><p>Peak sodium current values were converted to conductance values using the equation:<italic> G </italic>= <italic>I</italic>/(<italic>V</italic><sub>m </sub>- <italic>E</italic><sub>Na</sub>), where <italic>G </italic>is the conductance, <italic>I </italic>is the peak current amplitude, <italic>V</italic><sub>m </sub>is the membrane potential, and <italic>E</italic><sub>Na </sub>is the equilibrium potential value for Na<sup>+</sup>. The Boltzmann equation used to describe the voltage dependence of activation was of the form: <italic>G/G</italic><sub><italic>max </italic></sub>= 1/(1 + <italic>exp </italic>[(<italic>V</italic><sub>1/2 </sub>- <italic>V</italic><sub><italic>m</italic></sub>)/<italic>k</italic>]), where <italic>G</italic><sub>max </sub>is the peak conductance, <italic>V</italic><sub>1/2 </sub>is the potential at half maximal activation, and <italic>k </italic>is the slope factor. Voltage dependence of steady-state inactivation was described by the Boltzmann function: <italic>I</italic>/<italic>I</italic><sub><italic>max </italic></sub>= 1/(1 + <italic>exp </italic>[(<italic>V</italic>-<italic>V</italic><sub>1/2</sub>)/<italic>k</italic>]), where <italic>I</italic><sub>max </sub>is the maximal peak current, <italic>V </italic>is the prepulse membrane potential, <italic>V</italic><sub>1/2 </sub>is the potential at half maximal activation, and <italic>k </italic>is the slope factor.</p><p>Data are expressed as means &#x000b1; standard error of the mean (SEM). Statistical analysis was performed using SigmaStat software (Systat Software, Chicago, IL). Student's t-test or Mann-Whitney analysis was used to assess differences between means from two groups. One-way ANOVA or Kruskal-Wallis one-way ANOVA was used to assess difference among more groups. <italic>P </italic>&#x0003c; 0.05 was considered significant. Curves were plotted and fitted using Origin software (OriginLab Corporation, Northampton, USA).</p></sec></sec><sec><title>Abbreviations</title><p>SP: Substance P; DRG: dorsal root ganglion; NK-1: neurokinin-1; TRPV1: transient receptor potential vanilloid 1; TTX: tetrodotoxin; Sar-SP: [Sar<sup>9</sup>, Met(O<sub>2</sub>)<sup>11</sup>]-substance P; PKC: protein kinase C; BIM: bisindolylmaleimide; PKA: protein kinase A; PGE<sub>2</sub>: prostaglandin E<sub>2</sub>; PMA: phorbol 12-myristate 13-acetate; CFA: complete Freund's adjuvant.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>CLC and HZ performed the patch clamp recordings in DRG neurons. YQZ was partially involved in experimental design and guiding. ZQZ is the corresponding author.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This work was supported by grant from the National Basic Research Program of China Grant 2006CB500807 and the National Natural Science Fund of China 30600178.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>YQ</given-names></name><name><surname>Mantyh</surname><given-names>PW</given-names></name><name><surname>Carlson</surname><given-names>EJ</given-names></name><name><surname>Gillespie</surname><given-names>AM</given-names></name><name><surname>Epstein</surname><given-names>CJ</given-names></name><name><surname>Basbaum</surname><given-names>AI</given-names></name></person-group><article-title>Primary afferent tachykinins are required to experience moderate to intense pain</article-title><source>Nature</source><year>1998</year><volume>392</volume><fpage>390</fpage><lpage>394</lpage><pub-id pub-id-type="pmid">9537322</pub-id><pub-id pub-id-type="doi">10.1038/32897</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quartara</surname><given-names>L</given-names></name><name><surname>Maggi</surname><given-names>CA</given-names></name></person-group><article-title>The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles</article-title><source>Neuropeptides</source><year>1998</year><volume>32</volume><fpage>1</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">9571643</pub-id><pub-id pub-id-type="doi">10.1016/S0143-4179(98)90015-4</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>CJ</given-names></name><name><surname>Mannion</surname><given-names>RJ</given-names></name><name><surname>Neumann</surname><given-names>S</given-names></name></person-group><article-title>Null mutations lacking substance: elucidating pain mechanisms by genetic pharmacology</article-title><source>Neuron</source><year>1998</year><volume>20</volume><fpage>1063</fpage><lpage>1066</lpage><pub-id pub-id-type="pmid">9655494</pub-id><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80487-0</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khawaja</surname><given-names>AM</given-names></name><name><surname>Rogers</surname><given-names>DF</given-names></name></person-group><article-title>Tachykinins: receptor to effector</article-title><source>Int J Biochem Cell Biol</source><year>1996</year><volume>28</volume><fpage>721</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">8925404</pub-id><pub-id pub-id-type="doi">10.1016/1357-2725(96)00017-9</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mantyh</surname><given-names>PW</given-names></name><name><surname>Rogers</surname><given-names>SD</given-names></name><name><surname>Honore</surname><given-names>P</given-names></name><name><surname>Allen</surname><given-names>BJ</given-names></name><name><surname>Ghilardi</surname><given-names>JR</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Daughters</surname><given-names>RS</given-names></name><name><surname>Lappi</surname><given-names>DA</given-names></name><name><surname>Wiley</surname><given-names>RG</given-names></name><name><surname>Simone</surname><given-names>DA</given-names></name></person-group><article-title>Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor</article-title><source>Science</source><year>1997</year><volume>278</volume><fpage>275</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">9323204</pub-id><pub-id pub-id-type="doi">10.1126/science.278.5336.275</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname><given-names>ML</given-names></name><name><surname>Allen</surname><given-names>BJ</given-names></name><name><surname>Rogers</surname><given-names>SD</given-names></name><name><surname>Ghilardi</surname><given-names>JR</given-names></name><name><surname>Honore</surname><given-names>P</given-names></name><name><surname>Luger</surname><given-names>NM</given-names></name><name><surname>Finke</surname><given-names>MP</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Lappi</surname><given-names>DA</given-names></name><name><surname>Simone</surname><given-names>DA</given-names></name><name><surname>Mantyh</surname><given-names>PW</given-names></name></person-group><article-title>Transmission of chronic nociception by spinal neurons expressing the substance P receptor</article-title><source>Science</source><year>1999</year><volume>286</volume><fpage>1558</fpage><lpage>1561</lpage><pub-id pub-id-type="pmid">10567262</pub-id><pub-id pub-id-type="doi">10.1126/science.286.5444.1558</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>R</given-names></name><name><surname>Morcuende</surname><given-names>S</given-names></name><name><surname>Webber</surname><given-names>M</given-names></name><name><surname>Hunt</surname><given-names>SP</given-names></name><name><surname>Dickenson</surname><given-names>AH</given-names></name></person-group><article-title>Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways</article-title><source>Nat Neurosci</source><year>2002</year><volume>5</volume><fpage>1319</fpage><lpage>1326</lpage><pub-id pub-id-type="pmid">12402039</pub-id><pub-id pub-id-type="doi">10.1038/nn966</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carlton</surname><given-names>SM</given-names></name><name><surname>Coggeshall</surname><given-names>RE</given-names></name></person-group><article-title>Inflammation-induced up-regulation of neurokinin 1 receptors in rat glabrous skin</article-title><source>Neurosci Lett</source><year>2002</year><volume>326</volume><fpage>29</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">12052531</pub-id><pub-id pub-id-type="doi">10.1016/S0304-3940(02)00299-9</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Cang</surname><given-names>CL</given-names></name><name><surname>Kawasaki</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>LL</given-names></name><name><surname>Zhang</surname><given-names>YQ</given-names></name><name><surname>Ji</surname><given-names>RR</given-names></name><name><surname>Zhao</surname><given-names>ZQ</given-names></name></person-group><article-title>Neurokinin-1 receptor enhances TRPV1 activity in primary sensory neurons via PKCepsilon: a novel pathway for heat hyperalgesia</article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><fpage>12067</fpage><lpage>12077</lpage><pub-id pub-id-type="pmid">17978048</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0496-07.2007</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akasu</surname><given-names>T</given-names></name><name><surname>Ishimatsu</surname><given-names>M</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name></person-group><article-title>Tachykinins cause inward current through NK1 receptors in bullfrog sensory neurons</article-title><source>Brain Res</source><year>1996</year><volume>713</volume><fpage>160</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">8724987</pub-id><pub-id pub-id-type="doi">10.1016/0006-8993(95)01506-X</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dray</surname><given-names>A</given-names></name><name><surname>Pinnock</surname><given-names>RD</given-names></name></person-group><article-title>Effects of substance P on adult rat sensory ganglion neurones in vitro</article-title><source>Neurosci Lett</source><year>1982</year><volume>33</volume><fpage>61</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">6185885</pub-id><pub-id pub-id-type="doi">10.1016/0304-3940(82)90130-6</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>K</given-names></name><name><surname>Nakazawa</surname><given-names>K</given-names></name><name><surname>Inoue</surname><given-names>K</given-names></name><name><surname>Fujimori</surname><given-names>K</given-names></name></person-group><article-title>Nonselective cation channels coupled with tachykinin receptors in rat sensory neurons</article-title><source>J Neurophysiol</source><year>1995</year><volume>73</volume><fpage>736</fpage><lpage>742</lpage><pub-id pub-id-type="pmid">7539060</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>HS</given-names></name><name><surname>Zhao</surname><given-names>ZQ</given-names></name></person-group><article-title>Small sensory neurons in the rat dorsal root ganglia express functional NK-1 tachykinin receptor</article-title><source>Eur J Neurosci</source><year>1998</year><volume>10</volume><fpage>1292</fpage><lpage>1299</lpage><pub-id pub-id-type="pmid">9749783</pub-id><pub-id pub-id-type="doi">10.1046/j.1460-9568.1998.00140.x</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akopian</surname><given-names>AN</given-names></name><name><surname>Sivilotti</surname><given-names>L</given-names></name><name><surname>Wood</surname><given-names>JN</given-names></name></person-group><article-title>A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons</article-title><source>Nature</source><year>1996</year><volume>379</volume><fpage>257</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">8538791</pub-id><pub-id pub-id-type="doi">10.1038/379257a0</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Djouhri</surname><given-names>L</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Okuse</surname><given-names>K</given-names></name><name><surname>Wood</surname><given-names>JN</given-names></name><name><surname>Berry</surname><given-names>CM</given-names></name><name><surname>Lawson</surname><given-names>SN</given-names></name></person-group><article-title>The TTX-resistant sodium channel Nav1.8 (SNS/PN3): expression and correlation with membrane properties in rat nociceptive primary afferent neurons</article-title><source>J Physiol</source><year>2003</year><volume>550</volume><fpage>739</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">12794175</pub-id><pub-id pub-id-type="doi">10.1113/jphysiol.2003.042127</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Renganathan</surname><given-names>M</given-names></name><name><surname>Cummins</surname><given-names>TR</given-names></name><name><surname>Waxman</surname><given-names>SG</given-names></name></person-group><article-title>Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons</article-title><source>J Neurophysiol</source><year>2001</year><volume>86</volume><fpage>629</fpage><lpage>640</lpage><pub-id pub-id-type="pmid">11495938</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akopian</surname><given-names>AN</given-names></name><name><surname>Souslova</surname><given-names>V</given-names></name><name><surname>England</surname><given-names>S</given-names></name><name><surname>Okuse</surname><given-names>K</given-names></name><name><surname>Ogata</surname><given-names>N</given-names></name><name><surname>Ure</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Kerr</surname><given-names>BJ</given-names></name><name><surname>McMahon</surname><given-names>SB</given-names></name><name><surname>Boyce</surname><given-names>S</given-names></name><name><surname>Hill</surname><given-names>R</given-names></name><name><surname>Stanfa</surname><given-names>LC</given-names></name><name><surname>Dickenson</surname><given-names>AH</given-names></name><name><surname>Wood</surname><given-names>JN</given-names></name></person-group><article-title>The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways</article-title><source>Nat Neurosci</source><year>1999</year><volume>2</volume><fpage>541</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">10448219</pub-id><pub-id pub-id-type="doi">10.1038/9195</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>SK</given-names></name><name><surname>Mikusa</surname><given-names>JP</given-names></name><name><surname>Hernandez</surname><given-names>G</given-names></name><name><surname>Baker</surname><given-names>S</given-names></name><name><surname>Shieh</surname><given-names>CC</given-names></name><name><surname>Neelands</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>XF</given-names></name><name><surname>Niforatos</surname><given-names>W</given-names></name><name><surname>Kage</surname><given-names>K</given-names></name><name><surname>Han</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>Involvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states</article-title><source>Pain</source><year>2006</year><volume>123</volume><fpage>75</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">16545521</pub-id><pub-id pub-id-type="doi">10.1016/j.pain.2006.02.011</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khasar</surname><given-names>SG</given-names></name><name><surname>Gold</surname><given-names>MS</given-names></name><name><surname>Levine</surname><given-names>JD</given-names></name></person-group><article-title>A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat</article-title><source>Neurosci Lett</source><year>1998</year><volume>256</volume><fpage>17</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">9832206</pub-id><pub-id pub-id-type="doi">10.1016/S0304-3940(98)00738-1</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>J</given-names></name><name><surname>Gold</surname><given-names>MS</given-names></name><name><surname>Kim</surname><given-names>CS</given-names></name><name><surname>Bian</surname><given-names>D</given-names></name><name><surname>Ossipov</surname><given-names>MH</given-names></name><name><surname>Hunter</surname><given-names>JC</given-names></name><name><surname>Porreca</surname><given-names>F</given-names></name></person-group><article-title>Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8</article-title><source>Pain</source><year>2002</year><volume>95</volume><fpage>143</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">11790477</pub-id><pub-id pub-id-type="doi">10.1016/S0304-3959(01)00391-8</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amir</surname><given-names>R</given-names></name><name><surname>Argoff</surname><given-names>CE</given-names></name><name><surname>Bennett</surname><given-names>GJ</given-names></name><name><surname>Cummins</surname><given-names>TR</given-names></name><name><surname>Durieux</surname><given-names>ME</given-names></name><name><surname>Gerner</surname><given-names>P</given-names></name><name><surname>Gold</surname><given-names>MS</given-names></name><name><surname>Porreca</surname><given-names>F</given-names></name><name><surname>Strichartz</surname><given-names>GR</given-names></name></person-group><article-title>The role of sodium channels in chronic inflammatory and neuropathic pain</article-title><source>J Pain</source><year>2006</year><volume>7</volume><fpage>S1</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">16632328</pub-id><pub-id pub-id-type="doi">10.1016/j.jpain.2006.01.444</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>England</surname><given-names>S</given-names></name><name><surname>Bevan</surname><given-names>S</given-names></name><name><surname>Docherty</surname><given-names>RJ</given-names></name></person-group><article-title>PGE2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade</article-title><source>J Physiol</source><year>1996</year><volume>495</volume><fpage>429</fpage><lpage>440</lpage><pub-id pub-id-type="pmid">8887754</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>MS</given-names></name><name><surname>Levine</surname><given-names>JD</given-names></name><name><surname>Correa</surname><given-names>AM</given-names></name></person-group><article-title>Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro</article-title><source>J Neurosci</source><year>1998</year><volume>18</volume><fpage>10345</fpage><lpage>10355</lpage><pub-id pub-id-type="pmid">9852572</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Kadoi</surname><given-names>J</given-names></name><name><surname>Nakano</surname><given-names>Y</given-names></name><name><surname>Mastumoto</surname><given-names>S</given-names></name></person-group><article-title>The effect of PKC activity on the TTX-R sodium currents from rat nodose ganglion neurons</article-title><source>Life Sci</source><year>2005</year><volume>78</volume><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">16111720</pub-id><pub-id pub-id-type="doi">10.1016/j.lfs.2005.04.053</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cummins</surname><given-names>TR</given-names></name><name><surname>Dib-Hajj</surname><given-names>SD</given-names></name><name><surname>Black</surname><given-names>JA</given-names></name><name><surname>Akopian</surname><given-names>AN</given-names></name><name><surname>Wood</surname><given-names>JN</given-names></name><name><surname>Waxman</surname><given-names>SG</given-names></name></person-group><article-title>A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons</article-title><source>J Neurosci</source><year>1999</year><volume>19</volume><fpage>RC43</fpage><pub-id pub-id-type="pmid">10594087</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rush</surname><given-names>AM</given-names></name><name><surname>Craner</surname><given-names>MJ</given-names></name><name><surname>Kageyama</surname><given-names>T</given-names></name><name><surname>Dib-Hajj</surname><given-names>SD</given-names></name><name><surname>Waxman</surname><given-names>SG</given-names></name><name><surname>Ranscht</surname><given-names>B</given-names></name></person-group><article-title>Contactin regulates the current density and axonal expression of tetrodotoxin-resistant but not tetrodotoxin-sensitive sodium channels in DRG neurons</article-title><source>Eur J Neurosci</source><year>2005</year><volume>22</volume><fpage>39</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">16029194</pub-id><pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.04186.x</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saab</surname><given-names>CY</given-names></name><name><surname>Cummins</surname><given-names>TR</given-names></name><name><surname>Waxman</surname><given-names>SG</given-names></name></person-group><article-title>GTP gamma S increases Nav1.8 current in small-diameter dorsal root ganglia neurons</article-title><source>Exp Brain Res</source><year>2003</year><volume>152</volume><fpage>415</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">12898089</pub-id><pub-id pub-id-type="doi">10.1007/s00221-003-1565-7</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quartara</surname><given-names>L</given-names></name><name><surname>Maggi</surname><given-names>CA</given-names></name></person-group><article-title>The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation</article-title><source>Neuropeptides</source><year>1997</year><volume>31</volume><fpage>537</fpage><lpage>563</lpage><pub-id pub-id-type="pmid">9574822</pub-id><pub-id pub-id-type="doi">10.1016/S0143-4179(97)90001-9</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vijayaragavan</surname><given-names>K</given-names></name><name><surname>Boutjdir</surname><given-names>M</given-names></name><name><surname>Chahine</surname><given-names>M</given-names></name></person-group><article-title>Modulation of Nav1.7 and Nav1.8 peripheral nerve sodium channels by protein kinase A and protein kinase C</article-title><source>J Neurophysiol</source><year>2004</year><volume>91</volume><fpage>1556</fpage><lpage>1569</lpage><pub-id pub-id-type="pmid">14657190</pub-id><pub-id pub-id-type="doi">10.1152/jn.00676.2003</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>EM</given-names></name><name><surname>Okuse</surname><given-names>K</given-names></name><name><surname>Wood</surname><given-names>JN</given-names></name><name><surname>Dolphin</surname><given-names>AC</given-names></name><name><surname>Moss</surname><given-names>SJ</given-names></name></person-group><article-title>cAMP-dependent phosphorylation of the tetrodotoxin-resistant voltage-dependent sodium channel SNS</article-title><source>J Physiol</source><year>1999</year><volume>516</volume><fpage>433</fpage><lpage>446</lpage><pub-id pub-id-type="pmid">10087343</pub-id><pub-id pub-id-type="doi">10.1111/j.1469-7793.1999.0433v.x</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cesare</surname><given-names>P</given-names></name><name><surname>Dekker</surname><given-names>LV</given-names></name><name><surname>Sardini</surname><given-names>A</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name><name><surname>McNaughton</surname><given-names>PA</given-names></name></person-group><article-title>Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat</article-title><source>Neuron</source><year>1999</year><volume>23</volume><fpage>617</fpage><lpage>624</lpage><pub-id pub-id-type="pmid">10433272</pub-id><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80813-2</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khasar</surname><given-names>SG</given-names></name><name><surname>Lin</surname><given-names>YH</given-names></name><name><surname>Martin</surname><given-names>A</given-names></name><name><surname>Dadgar</surname><given-names>J</given-names></name><name><surname>McMahon</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Hundle</surname><given-names>B</given-names></name><name><surname>Aley</surname><given-names>KO</given-names></name><name><surname>Isenberg</surname><given-names>W</given-names></name><name><surname>McCarter</surname><given-names>G</given-names></name><name><surname>Green</surname><given-names>PG</given-names></name><name><surname>Hodge</surname><given-names>CW</given-names></name><name><surname>Levine</surname><given-names>JD</given-names></name><name><surname>Messing</surname><given-names>RO</given-names></name></person-group><article-title>A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice</article-title><source>Neuron</source><year>1999</year><volume>24</volume><fpage>253</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">10677042</pub-id><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80837-5</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>GD</given-names></name><name><surname>Zhao</surname><given-names>ZQ</given-names></name></person-group><article-title>State-dependent phosphorylation of epsilon-isozyme of protein kinase C in adult rat dorsal root ganglia after inflammation and nerve injury</article-title><source>J Neurochem</source><year>2003</year><volume>85</volume><fpage>571</fpage><lpage>580</lpage><pub-id pub-id-type="pmid">12694383</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andoh</surname><given-names>T</given-names></name><name><surname>Nagasawa</surname><given-names>T</given-names></name><name><surname>Kuraishi</surname><given-names>Y</given-names></name></person-group><article-title>Expression of tachykinin NK1 receptor mRNA in dorsal root ganglia of the mouse</article-title><source>Brain Res Mol Brain Res</source><year>1996</year><volume>35</volume><fpage>329</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">8717372</pub-id><pub-id pub-id-type="doi">10.1016/0169-328X(95)00244-M</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szucs</surname><given-names>P</given-names></name><name><surname>Polgar</surname><given-names>E</given-names></name><name><surname>Spigelman</surname><given-names>I</given-names></name><name><surname>Porszasz</surname><given-names>R</given-names></name><name><surname>Nagy</surname><given-names>I</given-names></name></person-group><article-title>Neurokinin-1 receptor expression in dorsal root ganglion neurons of young rats</article-title><source>J Peripher Nerv Syst</source><year>1999</year><volume>4</volume><fpage>270</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">10642095</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCarson</surname><given-names>KE</given-names></name></person-group><article-title>Central and peripheral expression of neurokinin-1 and neurokinin-3 receptor and substance P-encoding messenger RNAs: peripheral regulation during formalin-induced inflammation and lack of neurokinin receptor expression in primary afferent sensory neurons</article-title><source>Neuroscience</source><year>1999</year><volume>93</volume><fpage>361</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">10430499</pub-id><pub-id pub-id-type="doi">10.1016/S0306-4522(99)00102-5</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>XW</given-names></name><name><surname>Goregoaker</surname><given-names>S</given-names></name><name><surname>Engler</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Mark</surname><given-names>L</given-names></name><name><surname>Crona</surname><given-names>J</given-names></name><name><surname>Terry</surname><given-names>R</given-names></name><name><surname>Hunter</surname><given-names>J</given-names></name><name><surname>Priestley</surname><given-names>T</given-names></name></person-group><article-title>Small interfering RNA-mediated selective knockdown of Na(V)1.8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic rats</article-title><source>Neuroscience</source><year>2007</year><volume>146</volume><fpage>812</fpage><lpage>821</lpage><pub-id pub-id-type="pmid">17367951</pub-id><pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.01.054</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roza</surname><given-names>C</given-names></name><name><surname>Laird</surname><given-names>JM</given-names></name><name><surname>Souslova</surname><given-names>V</given-names></name><name><surname>Wood</surname><given-names>JN</given-names></name><name><surname>Cervero</surname><given-names>F</given-names></name></person-group><article-title>The tetrodotoxin-resistant Na+ channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice</article-title><source>J Physiol</source><year>2003</year><volume>550</volume><fpage>921</fpage><lpage>926</lpage><pub-id pub-id-type="pmid">12824446</pub-id><pub-id pub-id-type="doi">10.1113/jphysiol.2003.046110</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bulaj</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>MM</given-names></name><name><surname>Green</surname><given-names>BR</given-names></name><name><surname>Fiedler</surname><given-names>B</given-names></name><name><surname>Layer</surname><given-names>RT</given-names></name><name><surname>Wei</surname><given-names>S</given-names></name><name><surname>Nielsen</surname><given-names>JS</given-names></name><name><surname>Low</surname><given-names>SJ</given-names></name><name><surname>Klein</surname><given-names>BD</given-names></name><name><surname>Wagstaff</surname><given-names>JD</given-names></name><name><surname>Chicoine</surname><given-names>L</given-names></name><name><surname>Harty</surname><given-names>TP</given-names></name><name><surname>Terlau</surname><given-names>H</given-names></name><name><surname>Yoshikami</surname><given-names>D</given-names></name><name><surname>Olivera</surname><given-names>BM</given-names></name></person-group><article-title>Synthetic muO-conotoxin MrVIB blocks TTX-resistant sodium channel NaV1.8 and has a long-lasting analgesic activity</article-title><source>Biochemistry</source><year>2006</year><volume>45</volume><fpage>7404</fpage><lpage>7414</lpage><pub-id pub-id-type="pmid">16752929</pub-id><pub-id pub-id-type="doi">10.1021/bi060159+</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ekberg</surname><given-names>J</given-names></name><name><surname>Jayamanne</surname><given-names>A</given-names></name><name><surname>Vaughan</surname><given-names>CW</given-names></name><name><surname>Aslan</surname><given-names>S</given-names></name><name><surname>Thomas</surname><given-names>L</given-names></name><name><surname>Mould</surname><given-names>J</given-names></name><name><surname>Drinkwater</surname><given-names>R</given-names></name><name><surname>Baker</surname><given-names>MD</given-names></name><name><surname>Abrahamsen</surname><given-names>B</given-names></name><name><surname>Wood</surname><given-names>JN</given-names></name><name><surname>Adams</surname><given-names>DJ</given-names></name><name><surname>Christie</surname><given-names>MJ</given-names></name><name><surname>Lewis</surname><given-names>RJ</given-names></name></person-group><article-title>muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>17030</fpage><lpage>17035</lpage><pub-id pub-id-type="pmid">17077153</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0601819103</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Natura</surname><given-names>G</given-names></name><name><surname>von Banchet</surname><given-names>GS</given-names></name><name><surname>Schaible</surname><given-names>HG</given-names></name></person-group><article-title>Calcitonin gene-related peptide enhances TTX-resistant sodium currents in cultured dorsal root ganglion neurons from adult rats</article-title><source>Pain</source><year>2005</year><volume>116</volume><fpage>194</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">15927395</pub-id><pub-id pub-id-type="doi">10.1016/j.pain.2005.04.002</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cardenas</surname><given-names>LM</given-names></name><name><surname>Cardenas</surname><given-names>CG</given-names></name><name><surname>Scroggs</surname><given-names>RS</given-names></name></person-group><article-title>5HT increases excitability of nociceptor-like rat dorsal root ganglion neurons via cAMP-coupled TTX-resistant Na(+) channels</article-title><source>J Neurophysiol</source><year>2001</year><volume>86</volume><fpage>241</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">11431505</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kwong</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>LY</given-names></name></person-group><article-title>Prostaglandin E2 potentiates a TTX-resistant sodium current in rat capsaicin-sensitive vagal pulmonary sensory neurones</article-title><source>J Physiol</source><year>2005</year><volume>564</volume><fpage>437</fpage><lpage>450</lpage><pub-id pub-id-type="pmid">15705651</pub-id><pub-id pub-id-type="doi">10.1113/jphysiol.2004.078725</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>M</given-names></name><name><surname>Sakamoto</surname><given-names>K</given-names></name><name><surname>Shigekawa</surname><given-names>M</given-names></name><name><surname>Nakanishi</surname><given-names>S</given-names></name><name><surname>Ito</surname><given-names>S</given-names></name></person-group><article-title>Multiple mechanisms of arachidonic acid release in Chinese hamster ovary cells transfected with cDNA of substance P receptor</article-title><source>Biochem Pharmacol</source><year>1994</year><volume>48</volume><fpage>1735</fpage><lpage>1741</lpage><pub-id pub-id-type="pmid">7526867</pub-id><pub-id pub-id-type="doi">10.1016/0006-2952(94)90459-6</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitsuhashi</surname><given-names>M</given-names></name><name><surname>Ohashi</surname><given-names>Y</given-names></name><name><surname>Shichijo</surname><given-names>S</given-names></name><name><surname>Christian</surname><given-names>C</given-names></name><name><surname>Sudduth-Klinger</surname><given-names>J</given-names></name><name><surname>Harrowe</surname><given-names>G</given-names></name><name><surname>Payan</surname><given-names>DG</given-names></name></person-group><article-title>Multiple intracellular signaling pathways of the neuropeptide substance P receptor</article-title><source>J Neurosci Res</source><year>1992</year><volume>32</volume><fpage>437</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">1279191</pub-id><pub-id pub-id-type="doi">10.1002/jnr.490320315</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname><given-names>Y</given-names></name><name><surname>Tsuchida</surname><given-names>K</given-names></name><name><surname>Negishi</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>S</given-names></name><name><surname>Nakanishi</surname><given-names>S</given-names></name></person-group><article-title>Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells</article-title><source>J Biol Chem</source><year>1992</year><volume>267</volume><fpage>2437</fpage><lpage>2442</lpage><pub-id pub-id-type="pmid">1370820</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>Y</given-names></name><name><surname>Blount</surname><given-names>P</given-names></name><name><surname>Sachais</surname><given-names>BS</given-names></name><name><surname>Hershey</surname><given-names>AD</given-names></name><name><surname>Raddatz</surname><given-names>R</given-names></name><name><surname>Krause</surname><given-names>JE</given-names></name></person-group><article-title>Ligand binding kinetics of substance P and neurokinin A receptors stably expressed in Chinese hamster ovary cells and evidence for differential stimulation of inositol 1,4,5-trisphosphate and cyclic AMP second messenger responses</article-title><source>J Neurochem</source><year>1992</year><volume>59</volume><fpage>740</fpage><lpage>745</lpage><pub-id pub-id-type="pmid">1321234</pub-id><pub-id pub-id-type="doi">10.1111/j.1471-4159.1992.tb09430.x</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>S</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Tanimoto</surname><given-names>T</given-names></name><name><surname>Saiki</surname><given-names>C</given-names></name><name><surname>Takeda</surname><given-names>M</given-names></name><name><surname>Shima</surname><given-names>Y</given-names></name><name><surname>Ohta</surname><given-names>H</given-names></name></person-group><article-title>Effect of 8-bromo-cAMP on the tetrodotoxin-resistant sodium (Nav 1.8) current in small-diameter nodose ganglion neurons</article-title><source>Neuropharmacology</source><year>2007</year><volume>52</volume><fpage>904</fpage><lpage>924</lpage><pub-id pub-id-type="pmid">17140607</pub-id><pub-id pub-id-type="doi">10.1016/j.neuropharm.2006.10.008</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thio</surname><given-names>CL</given-names></name><name><surname>Sontheimer</surname><given-names>H</given-names></name></person-group><article-title>Differential modulation of TTX-sensitive and TTX-resistant Na+ channels in spinal cord astrocytes following activation of protein kinase C</article-title><source>J Neurosci</source><year>1993</year><volume>13</volume><fpage>4889</fpage><lpage>4897</lpage><pub-id pub-id-type="pmid">8229203</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>JA</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Cummins</surname><given-names>TR</given-names></name><name><surname>Waxman</surname><given-names>SG</given-names></name></person-group><article-title>Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain</article-title><source>Pain</source><year>2004</year><volume>108</volume><fpage>237</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">15030943</pub-id><pub-id pub-id-type="doi">10.1016/j.pain.2003.12.035</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>HJ</given-names><suffix>3rd</suffix></name><name><surname>England</surname><given-names>JD</given-names></name><name><surname>Soignier</surname><given-names>RD</given-names></name><name><surname>Nolan</surname><given-names>P</given-names></name><name><surname>Minor</surname><given-names>LD</given-names></name><name><surname>Liu</surname><given-names>ZP</given-names></name><name><surname>Levinson</surname><given-names>SR</given-names></name><name><surname>Paul</surname><given-names>D</given-names></name></person-group><article-title>Ibuprofen blocks changes in Na v 1.7 and 1.8 sodium channels associated with complete Freund's adjuvant-induced inflammation in rat</article-title><source>J Pain</source><year>2004</year><volume>5</volume><fpage>270</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">15219259</pub-id><pub-id pub-id-type="doi">10.1016/j.jpain.2004.04.005</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Cummins</surname><given-names>TR</given-names></name><name><surname>Ishikawa</surname><given-names>K</given-names></name><name><surname>Dib-Hajj</surname><given-names>SD</given-names></name><name><surname>Black</surname><given-names>JA</given-names></name><name><surname>Waxman</surname><given-names>SG</given-names></name></person-group><article-title>SNS Na+ channel expression increases in dorsal root ganglion neurons in the carrageenan inflammatory pain model</article-title><source>Neuroreport</source><year>1998</year><volume>9</volume><fpage>967</fpage><lpage>972</lpage><pub-id pub-id-type="pmid">9601651</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villarreal</surname><given-names>CF</given-names></name><name><surname>Sachs</surname><given-names>D</given-names></name><name><surname>Cunha</surname><given-names>FQ</given-names></name><name><surname>Parada</surname><given-names>CA</given-names></name><name><surname>Ferreira</surname><given-names>SH</given-names></name></person-group><article-title>The role of Na(V)1.8 sodium channel in the maintenance of chronic inflammatory hypernociception</article-title><source>Neurosci Lett</source><year>2005</year><volume>386</volume><fpage>72</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">16043287</pub-id><pub-id pub-id-type="doi">10.1016/j.neulet.2005.04.060</pub-id></citation></ref></ref-list></back></article> 